Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of BF2.649 administered by
individual titration in narcoleptic patients with excessive daytime sleepiness (EDS)